EMD Millipore’s New SNAP i.d.(R) 2.0 System for Immunohistochemistry Minimizes Slide Handling

DARMSTADT, Germany -- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, has introduced the SNAP i.d.(R) 2.0 Protein Detection System for Immunohistochemistry (IHC), which streamlines immunohistochemistry workflows and significantly decreases slide handling time. The system enables parallel processing of up to 24 tissue slides at a time, making it easier to [...]

Certara Updates its Industry-leading PK/PD Phoenix Platform and Introduces Phoenix Quantum

PRINCETON, NJ –– Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1.4 of its Phoenix® product family at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition being held at the San Diego Convention Center from Nov. 2-6. Phoenix is the premier PK/PD software [...]

EMD Millipore’s Chromocult® Coliform Agar Established as Basis for New ISO® Standard for Enumeration of E. coli and Coliforms in Water Samples

Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, announces that EMD Millipore’s Chromocult® Coliform Agar (CCA) has been used by the International Organization for Standardization (ISO®) as the only suitable culture medium to develop a revised standard for enumerating coliform bacteria and E. coli in water samples to replace [...]

FEI Releases New Electronics Failure Analysis Applications for Helios NanoLab DualBeam Portfolio

Hillsboro, Ore. -— FEI (NASDAQ: FEIC) announced today the release of two new application packages for its third-generation Helios NanoLab™ DualBeam™ systems, including the latest addition to the family, the plasma-sourced Helios PFIB. The new application solutions address needs in integrated device (IC) manufacturing and failure analysis for fast plan-view delayering, and rapid, automated preparation [...]

BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa Trial of Embryonic Stem Cell-Derived OpRegen® for the Treatment of the Dry Form of Age-Related Macular Degeneration

ALAMEDA, Calif. & JERUSALEM -- BioTime, Inc. (NYSE MKT:BTX) and Cell Cure Neurosciences Ltd. (Cell Cure) today announced that the U.S. Food and Drug Administration (FDA) has cleared Cell Cure’s Investigational New Drug (IND) application to initiate a Phase I/IIa clinical trial of OpRegen® in patients with the severe form of age-related macular degeneration (AMD) [...]

Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters with U.S. Government

Hercules, CA — —Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced the full resolution of previously disclosed investigations by the U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) into past violations of the Foreign Corrupt Practices Act (FCPA) that occurred [...]

Horizon Discovery Group plc Appoints Dr David Smoller as an Executive Director

Cambridge, UK -- Horizon Discovery Group plc (LSE:HZD) (“Horizon” or “the Company”),a leading provider of research tools to support translational genomics and the development of personalized medicines, today announces the appointment of Dr David Smoller, Chief Business Officer of Horizon, as an Executive Director of the Board, with immediate effect. David recently joined Horizon as [...]

Agilent Technologies Spins Off Its Electronic Measurement Business, Keysight Technologies

SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) today announced it has completed the spinoff of its electronic measurement business, Keysight Technologies. Keysight will begin trading on the New York Stock Exchange today under the symbol KEYS. The separation was implemented through a spinoff of Keysight's common stock and is intended to be tax-free for [...]

RainDance Technologies Appoints Martin M.CoyneII and Glenn P.Muirto to Board of Directors

BILLERICA, Mass. — — RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Martin M. Coyne II and Glenn P. Muir to its Board of Directors. Coyne Brings Technology and Healthcare Industry Best Practices Mr. Coyne currently serves as a director of Akamai, a role [...]

Agilent Technologies Granted Dismissal in Patent Infringement Suit Brought by Genetic Technologies

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced that patent infringement litigation claims against Agilent's microarray, Bioanalyzer and GeneSpring products have been dismissed by Genetic Technologies, Ltd. No settlement was involved; instead, Genetic Technologies offered to dismiss its claims against Agilent. The parties today filed a mutual dismissal of all claims, in [...]

Access IBO on Knowledge Center